• Explore how AI models decode complex disease biology by identifying pathological features, mapping dysregulated pathways, and pinpointing high-confidence drug targets at a systems level.
• Learn how foundational and generative models accelerate de novo therapeutic discovery by predicting target–disease associations and streamlining early development decisions.
Sponsor(s):
BenchiSci
Speaker(s):
Casandra Mangroo
SVP, Strategic Alliances
BenchSci
Ari Allyn-Feuer
Director, AI Intelligence Product
GSK
Arvind Rao
Professor, Computational Medicine & Bioinformatics
University of Michigan
Time:
11:45 AM - 12:15 PM
Agenda Track No.:
Track 1
Session Type:
General Session (Presentation)